Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04530448 · ClinicalTrials.gov registry record · Phase 4
Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization
A Phase 4 study, sponsored by West Virginia University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT04530448 is a Phase 4 study that was terminated before completion, run by West Virginia University. The registered enrollment target is 3 participants.
The verdict
NCT04530448, a Phase 4 study, was terminated before completion, sponsored by West Virginia University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
Our overarching goal is to improve the outcomes of critically ill COVID-19 patients with or at risk for development of acute kidney injury (AKI). The objective of this study is to determine the role of a protocol to manage urine alkalization using a simple medication that has been used for a very long time, is safe, and without significant side-effects. We aim to determine the feasibility and safety of a urine alkalinization protocol for the prevention of AKI in patients testing positive for COVID-19.
Interventions
- OTHER Standard of Care
- DRUG Sodium bicarbonate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2020-10-05 |
| Est. Completion | 2021-07-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04530448
The ClinicalTrials.gov registry entry for NCT04530448 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is West Virginia University, which has 122 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT04530448 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04530448 about?
NCT04530448 is a clinical study titled "Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization". Our overarching goal is to improve the outcomes of critically ill COVID-19 patients with or at risk for development of acute kidney injury (AKI). The objective of this study is to determine the role of a protocol to manage urine alkalization using a simple medication that has been used for a very lo...
What is the current status of trial NCT04530448?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2020-10-05. Estimated completion is 2021-07-15.
What interventions are being tested in trial NCT04530448?
The interventions under investigation include: Standard of Care (OTHER), Sodium bicarbonate (DRUG).
Who is sponsoring clinical trial NCT04530448?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.